Chartwell Investment Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,729
Closed -$802K 443
2020
Q4
$802K Sell
12,729
-2,898
-19% -$180K 0.03% 372
2020
Q3
$1.05M Hold
15,627
0.04% 342
2020
Q2
$655K Sell
15,627
-4,597
-23% -$176K 0.03% 363
2020
Q1
$637K Buy
20,224
+1,464
+8% +$58.6K 0.03% 351
2019
Q4
$758K Buy
+18,760
New +$657K 0.03% 370

Other funds holding SILK

Chartwell Investment Partners's SILK Position: Q1 2021 in Review

Chartwell Investment Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 12,729 shares — an estimated $802K sold.

Chartwell Investment Partners first reported a position in SILK in Q4 2019 and held it in 5 quarters. The position peaked at $1.05M in Q3 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Chartwell Investment Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 12,729 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $802K.
  • Chartwell Investment Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Chartwell Investment Partners's Silk Road Medical, Inc. Common Stock position peaked at $1.05M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Chartwell Investment Partners's 13F filing for Q1 2021, filed 3 May 2021.